PD-L1 determination in cytological and histological samples in patients with non-small cell lung cancer Source: International Congress 2018 – Linear and radial EBUS and peripheral nodules Year: 2018
Correlation of P53 and CerbB-2 expression in the diagnostic biopsies and the corresponding resected tumors in non small cell lung caner Source: Eur Respir J 2004; 24: Suppl. 48, 43s Year: 2004
HER-2/neu expression in bioptic and surgical samples of non small cell lung carcinoma Source: Eur Respir J 2002; 20: Suppl. 38, 3s Year: 2002
Accuracy of cell typing in nonsmall cell lung cancer by EBUS/EUS–FNA cytological samples Source: Eur Respir J 2011; 38: 911-917 Year: 2011
Nonsmall cell lung carcinoma: diagnostic difficulties in small biopsies and cytological specimens Source: Eur Respir Rev, 26 (144) 170007; 10.1183/16000617.0007-2017 Year: 2017
Pathology of lung cancer: histology, cytology, immunohistochemistry and molecular pathology Source: Eur Respir Mon; 2010: 48: 272–296 Year: 2010
The value of immunohistochemical markers in the differential diagnosis of adenocarcinomas Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011
Immunohistochemical study of intratumoral micro vessels in resected non-small cell lung carcinomas, N-status, pTNM-stage and survival period of the patients Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007
Histological subtyping of non-small cell lung cancer using transbronchial biopsy specimens obtained with a small forceps Source: International Congress 2017 – How to reach peripheral lesions: (radial EBUS, CLE, navigation, etc.) and treat airleaks Year: 2017
Prognostic significance of MUC1 expression in resected lung adenocarcinoma Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008
An audit of prognostic significance of histological subtype in surgically resected adenocarcinomas Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016
Prognostic impact of nestin expression in resected large cell neuroendocrine carcinoma of the lung Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012
Cytology in differential diagnosis of histological types of NSCLC Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009
Pathology and immunohistochemistry of lung cancer Source: Eur Respir Mon; 2009: 44: 15–35 Year: 2009
Interobserver agreement in determining non-small cell lung cancer subtype in specimens acquired by EBUS-TBNA}, Source: Eur Respir J 2012; 40: 699-705 Year: 2012
Expression of caveolin-1 and ttf-1 in lung adenocarcinomas with various histological subtypes Source: Annual Congress 2009 - Lung cancer biology Year: 2009
Correlation of p53, EGFR and HER2 expression in the diagnostic biopsies and the corresponding resected tumours in NSCLC Source: Eur Respir J 2003; 22: Suppl. 45, 198s Year: 2003
Morphological and histological profile of lung masses Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs Year: 2008
Serum napsin A as a tumor marker for primary lung adenocarcinoma Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010